AMERANT BAN ($AMTB) posted quarterly earnings results for Q4 2025 on Thursday, January 22nd. The company reported earnings of $0.53 per share, beating estimates of $0.39 by $0.14. The company also reported revenue of $112,170,000, beating estimates of $110,221,455 by $1,948,545.
You can see Quiver Quantitative's $AMTB stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
AMERANT BAN Insider Trading Activity
AMERANT BAN insiders have traded $AMTB stock on the open market 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $AMTB stock by insiders over the last 6 months:
- JACK L KOPNISKY purchased 5,000 shares for an estimated $101,050
- JUAN ESTERRIPA (See remarks) sold 1,000 shares for an estimated $20,275
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
AMERANT BAN Hedge Fund Activity
We have seen 71 institutional investors add shares of AMERANT BAN stock to their portfolio, and 55 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ENDEAVOUR CAPITAL ADVISORS INC removed 391,671 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $7,547,500
- MILLENNIUM MANAGEMENT LLC added 386,710 shares (+756.2%) to their portfolio in Q3 2025, for an estimated $7,451,901
- KENNEDY CAPITAL MANAGEMENT LLC removed 325,547 shares (-59.3%) from their portfolio in Q3 2025, for an estimated $6,273,290
- GOLDMAN SACHS GROUP INC removed 303,303 shares (-33.3%) from their portfolio in Q3 2025, for an estimated $5,844,648
- ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC removed 293,953 shares (-80.8%) from their portfolio in Q4 2025, for an estimated $5,735,023
- CITADEL ADVISORS LLC removed 195,412 shares (-87.8%) from their portfolio in Q3 2025, for an estimated $3,765,589
- EMPOWERED FUNDS, LLC added 150,341 shares (+inf%) to their portfolio in Q3 2025, for an estimated $2,897,071
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
AMERANT BAN Analyst Ratings
Wall Street analysts have issued reports on $AMTB in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Raymond James issued a "Outperform" rating on 10/29/2025
- Piper Sandler issued a "Overweight" rating on 10/29/2025
To track analyst ratings and price targets for AMERANT BAN, check out Quiver Quantitative's $AMTB forecast page.
AMERANT BAN Price Targets
Multiple analysts have issued price targets for $AMTB recently. We have seen 3 analysts offer price targets for $AMTB in the last 6 months, with a median target of $22.0.
Here are some recent targets:
- Michael Rose from Raymond James set a target price of $23.0 on 01/07/2026
- Wood Lay from Keefe, Bruyette & Woods set a target price of $20.0 on 11/03/2025
- Stephen Scouten from Piper Sandler set a target price of $22.0 on 10/29/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
